These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion. Sanders SW; Moore JG; Day GM; Tolman KG Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040 [TBL] [Abstract][Full Text] [Related]
10. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of oral nizatidine. Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125 [TBL] [Abstract][Full Text] [Related]
12. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients acute duodenal ulcer. Cortot A; Guillemot F; Moreau J; Soule JC; Veyrac M; Alberola B; Pappo M Aliment Pharmacol Ther; 1992 Aug; 6(4):487-93. PubMed ID: 1420740 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of oral nizatidine and ranitidine on gastric volume and pH in patients undergoing gynaecological laparoscopy. Popat MT; Dyar OJ; Blogg CE Anaesthesia; 1991 Oct; 46(10):816-9. PubMed ID: 1683179 [TBL] [Abstract][Full Text] [Related]
14. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs. Savarino V Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412 [TBL] [Abstract][Full Text] [Related]
15. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Hurlimann S; Abbühl B; Inauen W; Halter F Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351 [TBL] [Abstract][Full Text] [Related]
16. Effect of preoperative oral use of erythromycin and nizatidine on gastric pH and volume. Memis D; Turan A; Karamanlioglu B; Guler T; Yurdakoc A; Pamukcu Z; Turan N Anaesth Intensive Care; 2002 Aug; 30(4):428-32. PubMed ID: 12180579 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G Digestion; 1989; 42(1):1-6. PubMed ID: 2568299 [TBL] [Abstract][Full Text] [Related]
18. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation. Lazzaroni M; Sangaletti O; Bianchi Porro G J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739 [TBL] [Abstract][Full Text] [Related]
19. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry. Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270 [TBL] [Abstract][Full Text] [Related]
20. The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion. Wajima Z; Shitara T; Inoue T; Yoshikawa T; Ogawa R Anaesth Intensive Care; 2000 Feb; 28(1):46-8. PubMed ID: 10701036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]